Profilbild von Dr. rer. nat. Thomas Viel

Dr. rer. nat. Thomas Viel

Für die Person sind keine aktuellen Zugehörigkeiten bekannt. Die Person ist nicht mehr an der Universität aktiv.

Curriculum Vitae (CV)

Molecular Imaging for the assessment of new therapies, including gene therapies, for the treatment of glioma
Molecular imaging Imaging of neuro-inflammation in neurodegenerative diseases

Akademische Ausbildung
10/2004 - 01/2008	Ph.D. in Molecular Biology and Imaging (CEA/I2BM, INSERM U803, Orsay, France) Study of the effect of siRNAs modifications on their activity / Study of the biodistribution and pharmacokinetics of the modified siRNAs using PET imaging and of their in vivo activity using BLI / Study using FRI of a tumour specific protein as targeting reagent
Berufliche Stationen
seit 07/2010	Postdoc at the European Institute for Molecular Imaging (EIMI)
07/2008 - 07/2010	Post-doc in the Max Planck Institute for Neurological Research (Cologne, Germany)

Publikationen

Combined PET imaging of the inflammatory tumor microenvironment identifies margins of unique radiotracer uptake Zinnhardt B, Pigeon H, Thézé B, Viel T, Wachsmuth L, Fricke IB, Schelhaas S, Honold L, Schwegmann K, Wagner S, Faust A, Faber C, Kuhlmann MT, Hermann S, Schäfers M, Winkeler A, Jacobs AH (2017) In: Cancer Research, 77(8) Art der Publikation: Forschungsartikel (Zeitschrift)
Preclinical evidence that 3′-deoxy-3′-[18F]fluorothymidine PET can visualize recovery of hematopoiesis after gemcitabine chemotherapy. Schelhaas S, Held A, Bäumer N, Viel T, Hermann S, Müller-Tidow C, Jacobs A. (2016) In: Cancer Research, 76(24) Art der Publikation: Forschungsartikel (Zeitschrift)
6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable… Fricke I, Viel T, Worlitzer M, Collmann F, Vrachimis A, Faust A, Wachsmuth L, Faber C, Dollé F, Kuhlmann M, Schäfers K, Hermann S, Schwamborn J, Jacobs A. (2016) In: European Journal of Neuroscience, 43(10) Art der Publikation: Forschungsartikel (Zeitschrift)
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers. O’Halloran P, Viel T, Murray D, Wachsmuth L, Schwegmann K, Wagner S, Kopka K, Jarzabek M, Dicker P, Hermann S, Faber C, Klasen T, Schäfers M, O’Brien D, Prehn J, Jacobs A, Byrne A. (2016) In: European Journal of Nuclear Medicine and Molecular Imaging, 43(9) Art der Publikation: Forschungsartikel (Zeitschrift)
Mechanistic interrogation of combination Bevacizumab/dual PI3K/mTOR inhibitor response in Glioblastoma implementing novel MR and PET imaging biomarkers O’Halloran PJ, Viel T, Murray DW, Wachsmuth L, Schwegmann K, Wagner S, Kopka K, Jarzabek MA, Dicker P, Hermann S, Faber C, Klasen T, Schäfers M, O’Brien D, Prehn J HM, Jacobs AH, Byrne1 AT (2016) In: European Journal of Nuclear Medicine and Molecular Imaging, 2016(9) Art der Publikation: Forschungsartikel (Zeitschrift)

Alle Publikationen anzeigen